Moberg Pharma: New Terbinafinee supplier has been submitted - Redeye

Redeye views the news from Moberg Pharma that they have submitted an additional Terbinafine supplier to the company’s registration dossier as positive as it comes early in 2024. This process will most likely be concluded by the end of the year. This step is essential to secure a long-term supply of Terbinafine. This move is imperative to launch in more countries in the future. This does not change the timetable for the launches going forward but indicates that the timetable for the pan-European launch is on track.

Länk till analysen i sin helhet: https://www.redeye.se/research/994279/moberg-pharma-new-terbinafinee-supplier-has-been-submitted?utm_source=finwire&utm_medium=RSS